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Abstract
This paper describes two SlipChip-based approaches to protein crystallization: a SlipChip-based free
interface diffusion (FID) method and a SlipChip-based composite method that simultaneously
performs microbatch and FID crystallization methods in a single device. The FID SlipChip was
designed to screen multiple reagents, each at multiple diffusion equilibration times, and was validated
by screening conditions for crystallization of two proteins, enoyl-CoA hydratase from
Mycobacterium tuberculosis and dihydrofolate reductase/thymidylate synthase from Babesia bovis
against 48 different reagents at 5 different equilibration times each, consuming 12 μL of each protein
for a total of 480 experiments using three SlipChips. The composite SlipChip was designed to screen
multiple reagents, each at multiple mixing ratios and multiple equilibration times, and was validated
by screening conditions for crystallization of two proteins, enoyl-CoA hydratase from
Mycobacterium tuberculosis and dihydrofolate reductase/thymidylate synthase from Babesia
bovis. To prevent cross-contamination while keeping the solution in the neck channels for FID stable,
the plates of the SlipChip were etched with a pattern of nanowells. This nanopattern was used to
increase the contact angle of aqueous solutions on the surface of the silanized glass. The composite
SlipChip increased the number of successful crystallization conditions and identified more conditions
for crystallization than separate FID and microbatch screenings. Crystallization experiments were
scaled up in well plates using conditions identified during the SlipChip screenings, and X-ray
diffraction data were obtained to yield the protein structure of dihydrofolate reductase/thymidylate
synthase at 1.95 Å resolution. This free-interface diffusion approach provides a convenient and high-
throughput method of setting up gradients in microfluidic devices, and may find additional
applications in cell-based assays.
Introduction
This paper describes a SlipChip-based approach to simultaneously perform two methods for
protein crystallization, microbatch and free interface diffusion (FID), in a single microfluidic
device. Currently, there are three challenges to protein crystallization: 1) to crystallize proteins,
a large chemical space must be searched to determine the conditions required. The search for
the right precipitants and the right concentrations of protein and precipitant is expedited by
faster experiments and smaller sample sizes,1–4 and a simple, fast, and controllable system
would advance the discovery of new protein structures. 2) A particularly attractive method to
crystallize proteins is nanoliter-scale FID because it explores the phase diagram for
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crystallization as both the concentration of protein and the concentration of precipitant are
gradually changed by diffusion, provides a higher transient supersaturation level for crystal
nucleation, and eliminates precipitation induced by fast mixing.5,6 Nanoliter-scale FID is
consequently efficient for crystallization,7 but currently it is only implemented with valve-
based systems.7–10 We emphasize that FID is mechanistically very similar to the well-
established counter diffusion methods11 that are typically implemented on microliter scales,
including chip-based12 and gel acupuncture-based approaches.13 The use of valves in FID
requires external control equipment, and valves are often composed of PDMS. PDMS devices
have the additional complication of requiring control of the atmosphere and evaporation.14
Valve-free, equipment-free approaches to implement FID would simply the method and make
it more widely available. 3) Different methods of crystallization explore different paths towards
the equilibrated condition where crystals of protein form, therefore yield different
crystallization results.7,15 These methods can be modified to alter the kinetics of
crystallization7,16 and thus explore different routes to form crystals of proteins; however,
different methods require different techniques to combine the protein solution and precipitant
solution. While it is desirable to use more than one method of crystallization, it is
technologically challenging to use two techniques in one experiment.
The SlipChip technology described in this paper addresses these challenges. It has been
demonstrated in both pre-loaded17 and user-loaded18 formats, and for simplicity in this paper
we illustrate the ideas using the user-loaded format. This paper makes two advances: We
developed a FID technique based on SlipChip and also combined FID and microbatch
techniques in one “composite” SlipChip.
Results and Discussion
We first designed the SlipChip to incorporate the FID method (Figure 1). The SlipChip was
designed to screen a sample against 16 different precipitants at five different equilibration
times. Each equilibration time was investigated in duplicate, for a total of 160 experiments in
a single SlipChip. The SlipChip could be configured to form 16 separate fluidic paths for the
precipitants, each containing 10 wells, and a single fluidic path for the protein sample
containing 160 wells (Figure 1A). The general construction of the SlipChip was the same as
previously described18 (see Supporting Information). To incorporate the FID method, when
the SlipChip was “slipped” to connect the protein wells and the precipitant wells, the
microchannels (ducts, 21 μm in depth) that had formed the continuous fluidic path for the
protein sample became the neck channel connecting the protein well to the precipitant well
(Figure 1D, F, see also supporting movie S1). By gradually increasing the distance between
the protein wells and the precipitant wells, the length of the neck was increased from 91 μm
to 491 μm; by decreasing the width of the ducts, the width of the neck was decreased from 104
μm to 58 μm (Figure 1F, from left to right). The geometry of the necks, defined as the length
of the neck channel divided by the cross-sectional area of the channel, was consequently altered
(neck parameters are provided in supporting information Table S1)
The geometry of the neck controlled the equilibration time (Figure 2, see also supporting movie
S1), and we found that the equilibration time increased linearly with the neck geometry (Figure
2E), which was consistent with our expectations and numerical simulations (data not shown).
We emphasize that equilibration time occurring in the steady state with fully developed
diffusion profiles is different that the time to establish these profiles, the latter time is expected
to scale with the square of distance. The FID experiments were set up easily in the SlipChip,
requiring no valves and only involving pipetting and slipping. In this approach, the ducts for
the protein sample were used to set up the FID experiments, so little sample was wasted.
Because the necks were designed to be thin compared to the wells containing precipitant or
protein, the change in volume caused by changing the neck geometry was negligible compared
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to the total volume of the crystallization trial. The volume of the neck constituted only 4–8%
of the total volume of the crystallization trial. In these experiments, we focused on how
changing the equilibration time affects protein crystallization and not on how changing the
volume affects protein crystallization.
We first tested the effect of equilibration time on the kinetics of crystallization by crystallizing
the photosynthetic reaction center from Blastochloris viridis using the FID SlipChip. As
expected, we found that as the equilibration time increased, the protein progressed from
precipitate to many small crystals to fewer larger crystals (Figure 2F). We then used the FID
SlipChip to screen crystallization conditions for two proteins, enoyl-CoA hydratase from
Mycobacterium tuberculosis and dihydrofolate reductase/thymidylate synthase from Babesia
bovis. Approximately 12 μL of each protein was consumed to screen against a screening kit
containing 48 precipitants for a total of 480 experiments (see Supporting Information Table
S2). This experiment was performed on three SlipChips, each SlipChip with 16 precipitants
and five conditions in duplicate per precipitant, for a total of 160 experiments per chip and
consuming 4 μL of protein per chip We also screened both proteins using our previously
described user-loaded SlipChip18 using the microbatch method against the same precipitants,
and compared the microbatch results to the FID results (Figure 6D).
The two proteins studied represent different kinetics of nucleation: enoyl-CoA hydratase
nucleates quickly while dihydrofolate reductase/thymidylate synthase nucleates slowly. For
enoyl-CoA hydratase, FID minimizes nucleation and yields crystals in conditions where only
precipitation is observed in microbatch. Using the FID SlipChip, we were able to obtain crystals
of enoyl-CoA hydratase under several conditions (Figure 3). Under conditions that yield
crystals in both methods, such as for the photosynthetic reaction center from Blastochloris
viridis, FID yields fewer large crystals (Figure 2F) while microbatch yields many small
crystals. For dihydrofolate reductase/thymidylate synthase, few crystallization trials were
successful in forming crystals. In trials where crystals formed, few crystals were obtained in
each trial, indicating that the crystallization of dihydrofolate reductase/thymidylate synthase
is nucleation-limited. Only one precipitant condition produced crystals using the FID method,
but three precipitant conditions produced crystals in the microbatch method (Figure 6D). These
results imply that proteins with different nucleation kinetics will require different
crystallization techniques, and using multiple techniques in parallel increases the likelihood of
identifying suitable conditions to produce protein crystals.
We designed a SlipChp that added another dimension to the screening process: in addition to
identifying a precipitant and its concentration for crystallization, the two methods (FID and
microbatch) were screened simultaneously (Figure 4). In this SlipChip one could also configure
one continuous fluidic path for the protein sample and 16 separate fluidic paths for different
precipitants. Wells designed for microbatch experiments and wells designed for FID
experiments were in each fluidic path, allowing a single protein to be screened against 16
precipitants each at multiple mixing ratios and equilibration times. We also designed the FID
wells to have multiple mixing ratios (1:2, 1:1, and 2:1), for a total of 176 experiments per chip,
five microbatch experiments and six FID experiments for each of 16 precipitants.
As we described previously,18 cross-contamination could potentially occur during the slipping
step (between Figure 4E and Figure 4F): a thin film of solution can form between the two plates
of the SlipChip, connecting the ducts and wells that should be separated. To eliminate this
cross-contamination, the contact angle between the solutions and the plates of the SlipChip in
the lubricant fluorocarbon must be greater than ~130°, and in other experiments we have spin-
coated the plates with thin layers of fluorinated ethylene propylene.18 In the FID method, the
solution in the neck channel is not stable at such high contact angles and tends to break up to
minimize the surface energy.19 We solved this problem by patterning the surface of the
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SlipChip to make it more hydrophobic than the surface inside the wells and neck channels. To
do so, we introduced an extra step of fine etching before washing off the coating left from the
previous etching steps (see Supporting Information). This generated patterns of 10 μm diameter
wells that were 250 nm deep (Figure 5). Without nanopatterning, the average contact angle of
the 0.1% N,N-Dimethyldodecylamine N-oxide (LDAO) sample solution was only 112.2°
(Figure 5C), with nanopatterning, the average contact angle of the same LDAO sample solution
was 134.2°. In addition, nanopatterning decreased the surface area of glass that was directly
exposed to the solution edge during the slipping step. The small wells trapped lubricating fluid
and created a barrier to prevent solution leakage.
The performance of the nanopatterning was affected by the geometry of the nanopattern,
including the nanowell size, spacing, and etched depth. We varied these parameters, and
measured the contact angle of each nanopatterning (Figure 5E). The contact angle was plotted
against the etched depth, but as the etched depth changed the surface area of the nanowells was
also changed, because etching of glass is isotropic. Both the depth and the surface area of the
nanowells should affect the contact angle, but here we have not done a detailed analysis of the
relative importance of these two factors; related effects have been studied previously.20,21 All
silanized glass with nanopatterning had a contact angle higher than glass without
nanopatterning, and the contact angle increased with the depth of etching. The contact angle
was above 130° for those glass plates where the nanopatterning depth was in the range of 196
nm ~3.81 μm. For nanopatterns with depth of 3.81 μm, the maximum contact angle was 153.62°
(RSD=1.01%, n=5, measured after 5min of droplet setup). In all experiments, we found that
the contact angle decreased with time, as observed by measuring contact angle 5 min later. The
amount of the decrease was affected by the nanopattern depth. Nanopatterns with less than 200
nm depth had a faster decrease in contact angle than those nanopaterns that were deeper than
200 nm.
We then tested the composite SlipChip by using it to screen conditions for crystallization of
the same two proteins we had already studied using separate FID and microbatch experiments,
enoyl-CoA hydratase from Mycobacterium tuberculosis and dihydrofolate reductase/
thymidylate synthase from Babesia bovis (Figure 6). The composite approach made the search
for relevant crystallization conditions more efficient, as two routes to nucleation and crystal
growth were investigated simultaneously, while the same small amount of protein (~ 12 μL)
was consumed to screen each protein against the same screening kit. Both microbatch and free-
interface diffusion components of the composite SlipChip functioned, and identified
crystallization conditions for both proteins (Figure 6D). In the composite SlipChip, the majority
of conditions identified by separate microbatch and FID screenings were also identified. For
enoyl-CoA hydratase, two new conditions not identified in either of the individual screens were
picked up by the hybrid screen. For dihydrofolate reductase/thymidylate synthase, one
condition identified in the individual screens was lost. It was surprising to find new conditions
using the composite SlipChip, since fewer concentrations were being sampled for each
crystallization condition, but we doubt that this is due to any “magic” in the composite approach
that leads to more hits or due to accidental slipping after the mixtures are generated. The most
likely explanation of these observations is the intrinsic stochasticity of protein crystallization.
In addition, the cause of the discrepancy between individual experiments and the composite
experiment could be due to the variability among the protein samples used on different days,
or slight variability in surface coatings of the SlipChips. We expect that as these SlipChips are
used with more protein samples, these effects will become better understood.
Finally, to test whether the conditions identified could be scaled up, we scaled up one of the
three conditions for crystallization of dihydrofolate reductase/thymidylate synthase identified
in the microbatch SlipChip. The condition chosen was the protein sample at a mixing ratio of
0.33:0.57 with 20 % (w/v) PEG-8000, 0.2 M NaCl and 0.1 M CHES, pH 9.5. We scaled up
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dihydrofolate reductase/thymidylate synthase instead of enoyl-CoA hydratase because
dihydrofolate reductase/thymidylate synthase is more difficult to crystallize, as indicated by
fewer recognized hits (Figure 6D). The precipitant, 20 % (w/v) PEG-8000, 0.2 M NaCl and
0.1 M CHES, pH 9.5, produced crystals with best-defined shape at the chosen mixing ratio.
The microbatch method is straightforward to translate the crystallization trial from SlipChips
to well plates,18 and we successfully obtained crystals from the scale up experiment. We
collected a full X-ray diffraction data set and determined the structure at a resolution of 1.95
Å, space group P212121 (Figure 7 and Table S3). The structure has been deposited in the Protein
Data Bank (www.pdb.org), PBDid: 3KJR. The same protein was screened in parallel using
Seattle Structural Genomics Center for Infectious Disease (SSGCID) and Accelerated
Technologies Center for Gene to 3D Structure (ATCG3D) facilities to yield crystals using
microfluidic microbatch in a crystal card22 in conditions using 20% (w/v) PEG-8000, 0.1M
CHES pH 9.5. These crystals yielded a 2.35 Å structure, space group P1 (PDBid 3I3R). We
emphasize that the screens were conducted double-blind, without any information about
crystallization conditions shared until after the screens were completed and crystals were
obtained--the screening of crystallization of dihydrofolate reductase/thymidylate synthase on
the SlipChip and the concomitant sale up experiments were performed without any knowledge
of conditions obtained by the screening in facilities SSGCID and ATCG3D. We are encouraged
that similar conditions, sharing the same PEG and buffer and different only by the presence of
NaCl in the SlipChip screen, were independently discovered to yield structures. It was even
more encouraging that we obtained a higher resolution structure, with a different space group.
The 1.95 Å structure obtained in this paper, by virtue of a different space group, provided
complementary structural information to the 2.35 Å structure (PDBid 3I3R). The interpretation
of the structures is beyond the scope of this paper and will be published elsewhere.
Conclusions
This paper demonstrates a SlipChip-based FID approach to crystallize proteins and a composite
SlipChip-based approach to use microbatch and FID crystallization techniques simultaneously.
The SlipChip provides a simple and relatively easy-to-use method to set up 160 experiments
in free interface diffusion and 176 experiments in both microbatch and free interface diffusion,
and all experiments can be setup simultaneously with a single slip. For applications where each
experiment needs to be controlled individually, valve-based systems can be attractive. For
applications such as protein crystallization, where each trial does not need to be controlled
individually, the absence of valves dramatically simplifies both the execution of experiments
and fabrication of devices. Fabrication of devices is further simplified by using a SlipChip
platform, because the SlipChip should be compatible with inexpensive molding technologies
and common plastics. More advanced techniques already demonstrated in plug-based
crystallization techniques23–25 should be compatible with the SlipChip design. In addition to
screening multiple precipitants, mixing ratios, and equilibration times, the composite SlipChip
enables the comparison of two different protein crystallization techniques on the nanoliter scale
in the same device. By using a single device, the surface chemistries and solutions used are the
same, and any advantage of one method over the other can be identified and realized.
Microbatch corresponds to rapid mixing through a larger interface, leading to more rapid
nucleation. Free interface diffusion corresponds to slower mixing through a smaller interface,
corresponding to slower nucleation. Control of the neck geometry enables the exploration of
the continuum of methods bridging microbatch and FID methods. Crystallization based on
counter diffusion approaches is mechanistically similar to FID methods. Using methodologies
similar to the one described here, counter diffusion for crystallization can be implemented on
SlipChip on smaller scale and in more multiplexed format than in traditional methods. The
composite SlipChip provides a platform on which to test many proteins and the opportunity to
learn more about important characteristics of protein crystallization.
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After crystallization conditions are identified, high-quality crystals suitable for X-ray
diffraction are needed to characterize the crystals and determine protein structures. To produce
crystals large enough for X-ray diffraction, typically a minimum trial volume of ~10 nl is
required,7,26 and even much smaller crystals can be analyzed using recent advances in
synchrotron x-ray science,27so the crystals obtained in the SlipChip should be large enough
for structural characterization. There are two options to obtain X-ray diffraction data from
crystals grown in a SlipChip: extraction of crystals or in situ diffraction. The SlipChip is not
sealed, therefore, our preliminary experiments indicate, the two plates can be separated and
crystals extracted as has been done for a well-based chip,28 although this remains to be carefully
tested with the SlipChip. Diffraction in situ may prevent damage to the crystals during post-
crystallization manipulations and may increase throughput, but also remains to be tested with
the SlipChip. To enable X-ray diffraction in situ in the SlipChip, the the SlipChip can be
constructed of material that is compatible with in situ diffraction, such as PDMS, PMMA, and
cyclo-olefin-copolymers, or the glass can be etched to create wells with thinner walls.23,29,30
If it is found that for whatever reason some crystals grown in a SlipChip cannot give high-
quality X-ray diffraction data, the crystallization experiments can be scaled up using the
conditions identified by the SlipChip screenings. Microbatch experiments are easily scaled-up
in well plates, as we have shown for this paper. Another success has been achieved using the
same strategy with ribose-phosphate pyrophosphokinase from Burkholderia pseudomallei.
The condition (20% (w/v) PEG-3350, 0.2M magnesium formate, pH 5.9) recognized by
conventional vapor diffusion method yielded crystals in space group of I222. The crystal
structure was determined at 2.3 Å resolution (PDBid: 3DAH). In parallel using the SlipChip,
we recognized a different condition (11% (w/v) PEG-8000, 37 mM sodium citrate, pH 5.5)
yielding crystals in space group of P43212. We obtained a data set at 1.83 Å with crystals
produced by scaling up, and the structural determination and PDB deposition is in progress.
FID experiments are less trivial to scale up because the diffusion profiles and kinetics need to
be replicated and thoughtfully controlled on a larger scale. The predictable diffusion profile
we determined for FID SlipChip (Figure 2) should enable rational design of scalable SlipChips
both down to picoliter-scales and up to microliter-scales. If the predicted diffusion profile
applies at all scales, we can screen the crystallization conditions at a very small scale and scale
up the hits to the desirable volume. Such work is in progress.
The technology described here has a number of additional applications beyond protein
crystallization. For example, the nanometer-scale etching used to create a superhydrophobic
surface that we introduce in this paper will impact surface patterning technologies.31,32 In
addition, the techniques used for the FID method can be expanded to control equilibration times
when combining solutions in other experiments. This control of equilibration can be useful for
setting up concentration gradients in a range of applications, e.g. when studying chemotaxis
and in other cell-based assays.
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Refer to Web version on PubMed Central for supplementary material.
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A SlipChip designed to screen a protein against 16 different precipitants using the FID method
of crystallization. A) A schematic of the SlipChip. Multiple precipitants (purple, blue, red, and
pink), as well as multiple equilibration times for mixing the protein (orange) with each
precipitant, can be screened on the same SlipChip. B–F) A zoomed-in schematic of the area
outlined in A showing the operation of the SlipChp. B) The top plate (contoured in black)
contains ducts for the protein and ducts for the precipitant. The ducts for the protein will become
the neck channels that connect the protein wells and the precipitant wells, and these ducts
gradually decrease in width from left to right, gradually changing the equilibration time. C)
The bottom plate (contoured in red) has wells for the protein and wells for the precipitant. The
distance between the wells for the protein and wells for the precipitant is gradually increased
from left to right, gradually changing the equilibration time. D) When the two plates are
assembled, the fluidic path for the protein and the fluidic path for the precipitants are formed.
E) Solutions of protein (yellow) and precipitant (blue) after loading by pipetting. F) After
“slipping”, protein and precipitant wells from the bottom plate are bridged by narrow channels
in the top plate.
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Changing the geometry of the channel changes the equilibration time in the SlipChip. A–C)
Microphotographs of food dye diffusing in the FID SlipChip. Each condition represents a
different equilibration time, and was done in duplicate. A) Immediately after slipping, T1 = 0
min. B) At time T2 = 24 min. C) At time T3 = 141 min. D) Diffusion profiles were obtained
for various neck geometries by using a model fluorescent dye, DTPA. Average intensities in
the well for protein were measured by linescan through the wells (See, Figure S3). The diffusion
profiles depended on the neck geometry. Conditions correspond to the microphotographs in
A–C, time of the microphotographs taken in A–C are marked on the curve with dashed lines.
E) The 50% equilibration time and neck geometry are linearly related. 50% equilibration time
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was defined as the time it took for the average intensity in the protein wells to reach half of the
maximum equilibrated intensity; neck geometry was defined by the length of the neck divided
by the cross-sectional area of the neck. F) Microphotograph of the FID SlipChip containing
the protein (photosynthetic reaction center from Blastochloris viridis) and the precipitant (4 M
(NH4 )2 SO4 in 50 mM Na2 HPO4 /NaH2 PO4 buffer, pH 6.0). At the shortest equilibration
time, only precipitates were obtained (left zoom-in). As equilibration time increased, fewer,
larger crystals were obtained (middle and right zoom-ins).
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Microphotographs of crystals of enoyl-CoA hydratase from Mycobacterium tuberculosis
obtained from SlipChip-based FID. A) A crystal obtained from reagent 15, 20% (w/v)
PEG-3000 in imidazole buffer, pH 8.0; B) A crystal obtained from reagent 41, 45% (w/v)
PEG-3000 in 0.1 M CHES buffer, pH 9.5; C) A crystal obtained from reagent 8, 2.8 M
(NH4)2SO4 in 0.1 M citrate buffer, pH 5.5; D) A crystal obtained from reagent 14, 1.4 M
sodium citrate in 0.1M cacodylate buffer, pH 6.5. Reagent numbers correspond to numbering
in Table S1.
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Development of a composite SlipChip to combine microbatch and FID methods. (A) A
schematic of the composite SlipChip. Multiple precipitants (pink, blue, red, and orange) and
multiple volumes and equilibration times for mixing the protein (green) can be screened on the
same SlipChip using both microbath and FID methods. B–F) A zoomed-in schematic of the
area outlined in A showing the operation of the SlipChip. B) The top plate (contoured in black)
contains wells for the protein and ducts for the precipitant (microbatch) and ducts for both the
protein and precipitant (FID). C) The bottom plate (contoured in red) has ducts for the protein
and wells for the precipitant (microbatch) and wells for both the protein and precipitant (FID).
D) When the two plates are assembled, the fluidic path for the protein and the fluidic paths for
the precipitants are formed to fill wells for both microbatch and FID methods. E) A schematic
of solutions of protein (yellow) and precipitant (blue) filling wells after loading by pipetting.
The cross-sectional view (taken along the blue dotted lines in the schematic) shows the relative
position of the wells in the microbatch and FID methods before “slipping”. A microphotograph
of the food dye experiment demonstrates loading of the wells. F) A schematic of how protein
and precipitant wells from one plate can be connected after “slipping”. The cross-sectional
view (taken along the dotted blue lines in the schematic) shows how the wells containing protein
and wells containing precipitant are connected. In microbatch (left) the two wells are aligned
with one another, in FID (right) the two wells are connected by a narrow channel. A
microphotogragh of the food dye experiment demonstrates how the protein and precipitant are
combined in both microbatch and FID methods.
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Patterning hydrophobicity on the surface of the SlipChip with nanometer deep micropatterns.
A) Microphotograph of the surface of the SlipChip after nanopatterning. No nanopatterning is
present on the surface of the wells or microchannels. B) Zoomed-in microphotograph shows
the surface patterning of small wells 10 μm in diameter and 250 nm deep. C) Microphotograph
of a 4-μLaqueous droplet deposited on a surface silanized without nanopatterning. The droplet
contained 0.1% (w/v) LDAO. The contact angle was measured right after the deposition, and
was 115.4°. D) Microphotograph of a 4-μL aqueous droplet deposited on a surface silanized
with nanopatterning of 250 nm depth. The droplet contained 0.1% (w/v) LDAO. The contact
angle was measured right after the deposition, and was 137.9°. E) Contact angle of a 0.1%
LDAO solution on silanized glass with different nanopatterns. The nanopatterns were obtained
with the same nanopatterning photomask used to construct the SlipChips with nanopatterning
(10 μm size cross mesh with 10 μm spacing), but different nanowell depths were obtained by
changing the etching time. The contact angle was measured immediately after the droplet was
deposited on the glass plate (at 0 min) and again 5 min after the deposition.
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Re-screening of crystallization conditions for proteins using the composite SlipChip
reproduces results from microbatch and FID methods. (A) A microphotograph of the composite
SlipChip used to screen conditions to crystallize dihydrofolate reductase/thymidylate synthase.
All wells contain reagent 41 (45% (W/V) PEG-3000, 0.1 M CHES, pH 9.5). (B) Using the
microbatch method, crystals formed at a mixing ratio of 1:2 (protein:precipitant). (C) Using
the FID method, crystals formed at a mixing ratio of 1:2. Zoom views in B and C show a UV-
microscope picture of the protein crystal. (D) A summary of the crystallization results using
microbatch, FID, and composite SlipChips. Highlighted cells indicate that crystals formed.
Numbers above the cells refer to reagents listed in Table S1. The composite method produced
as many or more crystallization hits than either microbatch or FID alone for both enoyl-CoA
hydratase and dihydrofolate reductase/thymidylate synthase.
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Determination of the crystal structure of dihydrofolate reductase/thymidylate synthase (PDBid:
3KJR). (A) A microphotograph of crystals of dihydrofolate reductase/thymidylate synthase
grown in scale up experiments performed in well plates, by using the exact condition
recognized in microbatch SlipChip, at a mixing ratio of 0.33:0.67 with 20 % (w/v) PEG-8000,
0.2 M NaCl and 0.1 M CHES, pH 9.5. (B) An X-ray diffraction pattern obtained from crystals
in (A) at a region of 1.9 Å resolution. (C) Structure of dihydrofolate reductase/thymidylate
synthase (refined to 1.95 Å resolution) obtained from crystals grown in scale-up experiments.
The structure is displayed in cartoon generated using Pymol.
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